Episode 1: More Data on Suzetrigine

NEJM Clinician editors discuss results from phase 3 trials of suzetrigine, a novel, nonopioid pain medication.

Dr. Rahul Ganatra talks with Dr. Raja-Elie Abdulnour and Dr. Marie Claire O’Dwyer about the results of two phase 3 studies that led to the FDA approval for suzetrigine. What questions do you have about this new pain medication and how the data apply to the real world?

Journal Watch article

Anesthesiology paper

Episode 1: More Data on Suzetrigine5:39